Homology Medicines Inc banner

Homology Medicines Inc
SWB:35H

Watchlist Manager
Homology Medicines Inc Logo
Homology Medicines Inc
SWB:35H
Watchlist
Price: 14.85 EUR Market Closed
Market Cap: €4.1B

Wall St Price Targets

35H Price Targets Summary
Homology Medicines Inc

Wall Street analysts forecast 35H stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 35H is 19.06 EUR with a low forecast of 14.87 EUR and a high forecast of 23.79 EUR.

Lowest Forecast
Price Target
14.87 EUR
0% Upside
Average Forecast
Price Target
19.06 EUR
28% Upside
Highest Forecast
Price Target
23.79 EUR
60% Upside
Homology Medicines Inc Competitors:
Price Targets
WLFC
Willis Lease Finance Corp
25% Upside
BRI
Britania PCL
14% Upside
CREX
Creative Realities Inc
119% Upside
MTLS
Materialise NV
61% Upside
TARA
Protara Therapeutics Inc
525% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 35H's stock price target?
Price Target
19.06 EUR

According to Wall Street analysts, the average 1-year price target for 35H is 19.06 EUR with a low forecast of 14.87 EUR and a high forecast of 23.79 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett